Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Credit NIAID-RML
Highlighted Sections
Clinical Management Summary
This section contains figures with the Panel’s recommendations for the therapeutic management of adults with COVID-19 and children with MIS-C.
Critical Care for Children
These new sections provide recommendations for clinicians who are caring for critically ill pediatric patients with COVID-19.
Corticosteroids
The Panel expanded the discussion on dexamethasone dosing with recent results from several clinical trials.
Paxlovid Drug-Drug Interactions
This section provides resources for identifying and managing interactions between ritonavir-boosted nirmatrelvir and concomitant medications.
Antithrombotic Therapy
The Panel has added new recommendations on the use of antiplatelet therapy in patients with COVID-19.
Transplant
Ritonavir-boosted nirmatrelvir may have significant interactions with concomitant medications, including drugs that are used to prevent allograft rejection.
Clinical Management Summary
This section contains figures with the Panel’s recommendations for the therapeutic management of adults with COVID-19 and children with MIS-C.
Critical Care for Children
These new sections provide recommendations for clinicians who are caring for critically ill pediatric patients with COVID-19.
Corticosteroids
The Panel expanded the discussion on dexamethasone dosing with recent results from several clinical trials.
Paxlovid Drug-Drug Interactions
This section provides resources for identifying and managing interactions between ritonavir-boosted nirmatrelvir and concomitant medications.
Antithrombotic Therapy
The Panel has added new recommendations on the use of antiplatelet therapy in patients with COVID-19.
Transplant
Ritonavir-boosted nirmatrelvir may have significant interactions with concomitant medications, including drugs that are used to prevent allograft rejection.
Clinical Management Summary
This section contains figures with the Panel’s recommendations for the therapeutic management of adults with COVID-19 and children with MIS-C.
Critical Care for Children
These new sections provide recommendations for clinicians who are caring for critically ill pediatric patients with COVID-19.
Corticosteroids
The Panel expanded the discussion on dexamethasone dosing with recent results from several clinical trials.
Paxlovid Drug-Drug Interactions
This section provides resources for identifying and managing interactions between ritonavir-boosted nirmatrelvir and concomitant medications.
Antithrombotic Therapy
The Panel has added new recommendations on the use of antiplatelet therapy in patients with COVID-19.
Transplant
Ritonavir-boosted nirmatrelvir may have significant interactions with concomitant medications, including drugs that are used to prevent allograft rejection.